BIO-GATE AG O.N./ DE000BGAG981 /
| 2024-06-28 5:36:13 PM | Chg. -0.020 | Volume | Bid2024-06-28 | Ask2024-06-28 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.060EUR | -1.85% | 5,389 Turnover: 5,658.490 |
-Bid Size: - | -Ask Size: - | 8.48 mill.EUR | 0.00% | - |
Fundamentals
| FY 2021 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.07 EUR | -41.67% |
| EPS Diluted: | -0.07 EUR | -41.67% |
| Revenues per Share: | 0.81 EUR | 9.22% |
| Book Value per Share: | 0.50 EUR | 113.37% |
| Cash Flow per Share: | -0.08 EUR | -10.16% |
| Dividend per Share: | 0.00 EUR | - |
| Total | in mill. | |
| Revenues: | 6.20 EUR | 21.57% |
| Net Income: | -0.50 EUR | -37.50% |
| Operating Cash Flow: | -0.60 EUR | - |
| Cash and Cash Equivalents: | 2.00 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 1.37 | 4.78 |
| P/BV ratio: | 2.23 | 7.80 |
| P/CF Ratio: | -14.13 | -49.40 |
| PEG: | 0.38 | - |
| Earnings Yield: | -6.31% | -1.80% |
| Dividend Yield: | 0.00% | 0.00% |
| Market Capitalization | ||
| Market Capitalization: | 8.48 mill. EUR | 29.64 mill. EUR |
| Free Float Market Cap.: | 1.55 mill. EUR | 5.42 mill. EUR |
| Market Cap. / Employee: | 235,535.8333 EUR | 823,314.4444 EUR |
| Shares Outstanding: | 7.64 mill. | |
Profitability
| Gross Profit Margin: | 62.90% |
| EBIT Margin: | -8.06% |
| Net Profit Margin: | -8.06% |
| Return on Equity: | -13.16% |
| Return on Assets: | -9.62% |
Financial Strength
| Liquidity I / Cash Ratio: | - |
| Liquidity II / Quick Ratio: | - |
| Liquidity III / Current Ratio: | - |
| Debt / Equity Ratio: | 36.84% |
| Dynam. Debt / Equity Ratio: | -233.33% |
Efficiency
| Employees: | 36 |
| Personal Expenses / Employee: | 69,444.44 EUR |
| Revenues / Employee: | 172,222.22 EUR |
| Net Income / Employee: | -13,888.89 EUR |
| Total Assets / Employee: | 144,444.44 EUR |
| * Fiscal Year End: | 2021-12-31 |
| Accounting Standard: | HGB |
| Currency: | EUR |
